- recruitingPHASE1, PHASE2
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
This study looks at new drug combinations (Onivyde with talazoparib or temozolomide) for children and young adults with solid cancers that have come back or not responded to previous treatment, especially Ewing sarcoma. The aim is to find the safest, most effective dose.
United States · Canada - recruitingPHASE1
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
This study is testing a new drug, LY4052031, for people with advanced cancers like bladder, breast, and lung cancer. It aims to see if the drug is safe, what dose works best, and if it helps shrink tumors. It's an early-stage study to gather important information.
United States · Australia · China